Viewing nowCombinationAmozartan Q Tablets 5/50/5 mg (Amlodipine, Losartan, Rosuvastatin)
Amlodipine Camsylate 7.84mg · Rosuvastatin Calcium 5.2mg +1 more
Tablet · Prescription medication · Combination
Hanmi Pharmaceutical Co., Ltd.

MFDS item code 201705688 · Approved 2017.07.14 · Insurance code 643507830
Treatment of hypertension; improvement of dyslipidemia; inhibition of atherosclerosis progression and reduction of cardiovascular disease risk
This drug is used for patients with essential hypertension who have difficulty controlling blood pressure with monotherapy or for those who require combination therapy to achieve hypertension treatment goals. Additionally, Rosuvastatin helps in the treatment of hypercholesterolemia and mixed dyslipidemia that are not controllable through diet and exercise. This drug is also used as an adjunct to dietary therapy for patients with homozygous familial hypercholesterolemia, lowering total cholesterol and LDL-cholesterol to delay the progression of atherosclerosis. For men over 50 with elevated high-sensitivity C-reactive protein and additional risk factors for cardiovascular disease, as well as women over 60, a reduction in the risk of stroke, myocardial infarction, and revascularization procedures can also be expected. Therefore, this drug is used to effectively manage blood pressure and blood cholesterol to prevent and treat cardiovascular complications.
This medicine should be administered only to adults. The dose should be individualized for each patient based on the efficacy and tolerability of the amlodipine/losartan combination and rosuvastatin. ○ Amlodipine/losartan combination The recommended dose of the amlodipine/losartan combination in adults is 1 tablet once daily, taken with water, with or without food. It is recommended that the medicine be taken at the same time each day, if possible (e.g., in the morning). Before administering the amlodipine/losartan combination, it is recommended that the dose be adjusted using the individual components (amlodipine or losartan). However, if blood pressure is not adequately controlled with monotherapy using an individual component, switching directly to the amlodipine/losartan combination may be considered as follows. - 5/50 milligrams: Administer to patients whose blood pressure is not adequately controlled with amlodipine 5 milligrams or losartan 50 milligrams as monotherapy. - 5/100 milligrams: Administer to patients whose blood pressure is not adequately controlled with amlodipine 5 milligrams or losartan 100 milligrams as monotherapy. Before administering the amlodipine/losartan combination as initial therapy to patients with stage 2 hypertension, the decision to administer it should take into account baseline blood pressure, target blood pressure, and the expected likelihood of achieving the treatment goal with the combination compared with monotherapy. The usual dose is 5/50 milligrams once daily. If blood pressure is not adequately controlled after 2 weeks of treatment, the dose may be increased to 10/50 milligrams once daily. ∘ Patients with renal impairment: No dosage adjustment is necessary in patients with mild renal impairment (e.g., creatinine clearance 20∼50mL/min); however, administration of the amlodipine/losartan combination is not recommended in patients with moderate to severe renal impairment (e.g., creatinine clearance < 20 mL/min) or in patients undergoing dialysis. ∘ Patients with reduced intravascular volume: Administration of the amlodipine/losartan combination is not recommended in a small number of patients with reduced intravascular volume (e.g., patients being treated with high doses of diuretics). (See Section 1, Warnings, under Precautions for Use.) ∘ Patients with hepatic impairment: Administration of the amlodipine/losartan combination is not recommended in patients with a history of hepatic impairment who require a reduced dose of losartan (e.g., 25 milligrams once daily). ∘ Elderly patients: In elderly patients aged 75 years or older, an initial losartan dose of 25 milligrams once daily is recommended; therefore, use of the amlodipine/losartan combination as initial therapy is not recommended. ○ Rosuvastatin 1. Primary hypercholesterolemia (including heterozygous familial hypercholesterolemia, type IIa), combined dyslipidemia (type IIb), primary dysbetalipoproteinemia (type III), and homozygous familial hypercholesterolemia Patients should follow a standard cholesterol-lowering diet before and during treatment with rosuvastatin and should continue it throughout the treatment period. Rosuvastatin may be taken at any time of the day, with or without food. The initial dose in adults is 5 milligrams once daily. If a greater reduction in LDL cholesterol is needed, the dose may be adjusted to the maintenance dose. The maintenance dose is 10 milligrams once daily, which controls the condition in most patients. The maintenance dose should be adjusted as appropriate at intervals of 4 weeks or longer according to LDL cholesterol levels, the treatment goal, and the patient's response, and may be increased up to a maximum of 20 milligrams once daily. 2. Elderly patients: No dosage adjustment is necessary. 3. Patients with renal impairment: No dosage adjustment is necessary in patients with mild or moderate renal impairment. Do not administer to patients with severe renal impairment. Particular caution should be exercised when administering rosuvastatin 20mg to patients with moderate renal impairment. 4. Patients with hepatic impairment: No increase in systemic exposure to rosuvastatin was observed in patients with a Child-Pugh score of 7 or less, but an increase was observed in patients with a Child-Pugh score of 8 or 9. Renal function testing should be considered in these patients. There is no experience with administration to patients with a Child-Pugh score greater than 9. Do not administer rosuvastatin to patients with active liver disease. 5. Race: Because systemic exposure to rosuvastatin is increased in Asian patients, the recommended initial dose is 5 milligrams. Administration of the 40 milligrams dose is contraindicated. 6. Patients predisposed to myopathy: The recommended initial dose for patients predisposed to myopathy is 5 milligrams. Administration of the 40 milligrams dose of rosuvastatin is contraindicated in some of these patients. For patients taking the amlodipine/losartan combination and rosuvastatin concomitantly, switching to this medicine (a combination product containing the same amounts of each active ingredient) may be considered for convenience.
This drug can pose serious risks to the fetus during pregnancy; therefore, women who are pregnant or may become pregnant should avoid taking it. It may affect fetal kidney development, leading to conditions such as oligohydramnios, pulmonary hypoplasia, and skeletal defects, with risks of hypotension and renal failure in newborns. Caution should be exercised in patients with excessively low blood pressure or severely impaired kidney function, and consultation with a physician is essential before use. Patients allergic to any components of this drug or those with conditions such as hereditary angioedema or severe liver dysfunction should not take it. Elderly patients or those with compromised liver or kidney function should take it with caution due to increased risks of side effects. If muscle-related adverse symptoms such as myalgia, muscle weakness, or rhabdomyolysis occur, immediate notification to medical personnel is required, and discontinuation of the medication may be necessary. This drug may affect the liver and kidneys, so regular blood tests and liver function tests may be required. When taken with other antihypertensives, lipid-lowering agents, or diuretics, increased side effects may occur due to interactions, and use should follow a physician's directions. Particular caution is necessary when taken concurrently with potassium-sparing diuretics or potassium supplements due to the risk of hyperkalemia. This drug contains lactose, so patients with lactose intolerance should avoid it. If dizziness or hypotension occurs during use, operating vehicles or machinery should be avoided, and consultation with medical personnel is advised if symptoms persist. Pregnant or lactating women should not take this drug and should use appropriate contraceptive methods if planning for pregnancy. It is important to consult a physician or pharmacist immediately if any adverse symptoms occur during the use of this medication.
Craniosynostosis, anuria, hypotension, renal failure, upper respiratory infection, dizziness, dyspepsia, lower gastrointestinal bleeding, orthostatic dizziness, pre-syncope, rhabdomyolysis, pancreatic adenocarcinoma, dizziness, headache, drowsiness, cerebral infarction, asthenia, chest discomfort, chest pain, early satiety, peripheral edema, pitting edema, abdominal discomfort, nausea, gastroesophageal reflux disease, constipation, pruritus, urticaria, palpitations, flushing, orthostatic hypotension, facial flushing, dyspnea, cough, conjunctival injection, increased urination, angioedema, diabetes, constipation, nausea, abdominal pain, pruritus, myalgia, myopathy, rhabdomyolysis, asthenia, polyneuropathy, amnesia, peripheral neuropathy, diarrhea, thrombocytopenia, jaundice, hepatitis, increased transaminases, Stevens-Johnson syndrome, drug reaction with eosinophilia and systemic symptoms, lupus-like syndrome, muscle rupture, arthralgia, immune-mediated necrotizing myopathy, hematuria, edema, depression, sleep disorders, cough, dyspnea, rhinitis, alopecia, hyperhidrosis, purpura, skin discoloration, urticaria, toxic epidermal necrolysis, tinnitus, visual disturbances, increased urinary frequency, voiding dysfunction, nocturia, hepatitis, jaundice, increased liver enzyme levels, pruritus, rash, angioedema, erythema multiforme, myocardial infarction, arrhythmia, chest pain, hypotension, sinus block, atrioventricular block, abdominal discomfort, precordial pain, diarrhea, loose stools, constipation, skin flushing, maculopapular rash, heaviness, heat sensation, impaired glucose tolerance, weakness, asthenia, fatigue, pain, weight gain, weight loss, vasculitis, hypertonia, sensory loss, sensory disturbance, peripheral neuropathy, syncope, taste disturbance, tremor, extrapyramidal disorders, erectile dysfunction, gynecomastia, changes in bowel habits, dry mouth, gastritis, pancreatitis, vomiting, hyperglycemia, arthralgia, low back pain, muscle cramps, leukopenia, thrombocytopenia, insomnia, mood changes, rhinitis, alopecia, dermatitis, dry skin, petechial hemorrhage, erythema, flushing, photosensitivity reaction, pruritus, rash, sweating, urticaria, depression, nightmares, cough, epistaxis, rhinitis, respiratory congestion, chest discomfort, blurry vision, burning sensation in eyes, pain, conjunctivitis, taste disturbance, tinnitus, vision loss, erectile dysfunction, nocturia, increased urination, urethral infection, lip swelling, eyelid swelling, facial rash, vasculitis, anaphylactic-like syndrome, liver function abnormalities, hepatitis, intestinal vascular edema, fatigue, anemia, thrombocytopenia, myalgia, weakness, increased creatine kinase, elevated serum myoglobin, rhabdomyolysis, taste disturbance, dry cough, erythematous skin disease, hyperkalemia, hyponatremia, elevated ALT, headache, dizziness, increased ALT, elevated CK, weakness, arthralgia, fatigue, numbness, sensory disturbance, chest discomfort, loss of appetite, abdominal distension, syncope, generalized pain, muscle cramps, gout, erectile dysfunction, acute renal failure, oliguria, thrombocytopenia, increased serum creatinine, pulmonary edema, pneumonia, periodontal destruction, benign gastrointestinal neoplasm, gastric adenocarcinoma, cholelithiasis, cholangitis, liver cirrhosis, fracture, ligament injury, albuminuria, chronic renal failure, worsening of chronic renal failure, renal papillary necrosis, benign prostatic hyperplasia, uterine fibroids, ovarian cysts, cataracts, changes in temperature sensation, acute hepatitis, fulminant hepatitis, renal failure, ventricular ectopic beats, atrial fibrillation, hypoglycemia, weakness, hunger, diaphoresis, tremors, decreased concentration, convulsions, altered consciousness
Not everyone experiences these, and they can vary from person to person.
This drug may be sensitive to air or moisture; therefore, it should be stored in a tightly sealed container. The storage temperature should be kept between 1 and 30 degrees Celsius for optimal efficacy.
Bright yellow oval film-coated tablets
30 tablets/bottle, 100 tablets/bottle, 30 tablets/box [10 tablets/PTP x 3]
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Viewing nowCombinationAmlodipine Camsylate 7.84mg · Rosuvastatin Calcium 5.2mg +1 more
Tablet · Prescription medication · Combination
Hanmi Pharmaceutical Co., Ltd.
CombinationAmlodipine Camsylate 7.84mg · Rosuvastatin Calcium 10.4mg +1 more
Tablet · Prescription medication · Combination
Hanmi Pharmaceutical Co., Ltd.
CombinationAmlodipine Camsylate 7.84mg · Rosuvastatin Calcium 10.4mg +1 more
Tablet · Prescription medication · Combination
Hanmi Pharmaceutical Co., Ltd.
CombinationAmlodipine Camsylate 7.84mg · Rosuvastatin Calcium 20.8mg +1 more
Tablet · Prescription medication · Combination
Hanmi Pharmaceutical Co., Ltd.
CombinationAmlodipine Camsylate 7.84mg · Rosuvastatin Calcium 5.2mg +1 more
Tablet · Prescription medication · Combination
Hanmi Pharmaceutical Co., Ltd.
CombinationAmlodipine Camsylate 7.84mg · Rosuvastatin Calcium 20.8mg +1 more
Tablet · Prescription medication · Combination
Hanmi Pharmaceutical Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.